George Hartman

George D. Hartman, Ph.D., is the co-founder and vice president of chemistry and pre-clinical development of Novira Therapeutics. Prior to this role, Dr. Hartman was at Merck for over 35 years, rising to the level of executive director of medicinal chemistry, where he was responsible for the discovery and development of clinical candidates across multiple therapeutic areas, including cancer, schizophrenia, insomnia, Parkinson’s, inflammation, ophthalmics and anti-infectives. Dr. Hartman was the lead inventor for Aggrastat®, an anti-platelet agent used worldwide in the treatment of ischemic coronary disease.